Why Is Verve Therapeutics (VERV) Stock Down 28% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Verve Therapeutics (VERV) stock is taking a beating on Monday following bad news from the U.S. Food and Drug Administration (FDA).

The post Why Is Verve Therapeutics (VERV) Stock Down 28% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.